Khan, Hina N.
Brands, Xanthe
Aufiero, Simona
Hoogendijk, Arie J.
Klarenbeek, Augustijn M.
van Engelen, Tjitske S. R.
Haak, Bastiaan W.
van Vught, Lonneke A.
Horn, Janneke
Schultz, Marcus J.
Zwinderman, Aeilko H.
van der Poll, Tom
Scicluna, Brendon P. http://orcid.org/0000-0003-2826-0341
Funding for this research was provided by:
Center for Translational Molecular Medicine (grant 04I-201)
Article History
Received: 15 January 2020
Accepted: 3 July 2020
First Online: 13 July 2020
Ethics approval and consent to participate
: This study was part of the Molecular Diagnosis and Risk Stratification of sepsis (MARS) project, a prospective observational study in the mixed ICUs of two tertiary teaching hospitals in the Netherlands (Academic Medical Center, Amsterdam, and University Medical Center Utrecht, Utrecht) (ExternalRef removed identifier NCT01905033). The institutional review boards of both participating centers approved an opt-out consent method (IRB No. 10-056C). Written informed consent was provided by all healthy volunteers. All procedures complied with the Helsinki Declaration of 1975 (revised 1983).
: All authors reviewed and provided consent to publish the work described in this study.
: All authors declare no conflicts of interest.